Michael Sukkar MP visits Trajan Headquarters

Michael Sukkar MP visits Trajan Headquarters

February 04, 2015

Trajan's global headquarters located in Ringwood, Melbourne, was visited by Michael Sukkar MP, Member for Deakin, Parliament of Australia on 4 February, 2015.

Mr Sukkar was pleased to tour a growing local advanced manufacturing facility, with Trajan exporting products used in scientific and medical analysis to customers in over 100 countries.

In the past, Trajan's SGE Analytical Science brand of chromatography consumables has been awarded an R&D100 Technology Innovation Award, Victorian Exporter of the Year and inducted into Victoria’s Manufacturing Hall of Fame.

Apart from the production of specialized components, Trajan also services the local Australian clinical and medical research sectors with a wide range of pathology consumables through its Grale HDS brand.

Mr Sukkar said it was a privilege to visit Trajan’s headquarters in Ringwood and hear the inspirational story behind this growing business.

“Stephen Tomisich and his team are at the forefront of analytical and medical science, developing and commercializing technologies that will make a real difference to the health and well-being of our nation,” he said.

“I look forward to visiting again soon and supporting this business as it continues to go from strength to strength.”

Chief Executive Officer of Trajan Stephen Tomisich said "It was a great opportunity to share our journey so far, and how we plan to contribute to a strong future of technology innovation and manufacturing in Australia."

Photo: Trajan's CEO Stephen Tomisich (right) explaining the critical features of an analytical syringe to Michael Sukkar MP (left).




Also in News

US FDA listing of Trajan’s hemaPEN blood microsampling device
US FDA listing of Trajan’s hemaPEN blood microsampling device

July 02, 2020

Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

Read More

CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK
CE mark for Trajan’s hemaPEN blood microsampling device, now available for diagnostic use across EU and UK

May 07, 2020

Trajan Scientific and Medical has declared hemaPEN compliance with EU IVD Directive 98/79/EC, and its release for in vitro diagnostic use in the EU and UK. This follows the hemaPEN’s recent addition to the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class 1 IVD device.

Read More

New Trajan microtome blades, for any tissue type
New Trajan microtome blades, for any tissue type

April 28, 2020

Trajan Scientific and Medical releases new microtome blades in Australia, New Zealand, UK and EU, to provide the blade of choice for any tissue type. For histologists who have trouble finding a blade that offers both exceptional cutting and longevity, Trajan microtome blades have been designed to enable smooth and precise sectioning across a wide range of tissue specimens.

Read More